Skip to main content

Published locations for Once-Monthly Efimosfermin Leads to Significant MASH Improvement in Phase 2 Trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Once-Monthly Efimosfermin Leads to Significant MASH Improvement in Phase 2 Trial

User login

  • Reset your password
  • /content/once-monthly-efimosfermin-leads-significant-mash-improvement-phase-2-trial
  • /content/once-monthly-efimosfermin-leads-significant-mash-improvement-phase-2-trial
  • /gihepnews/article/272535/liver-disease/once-monthly-efimosfermin-leads-significant-mash-improvement-phase-2-trial
  • /taxonomy/term/79117/article/272535/liver-disease/once-monthly-efimosfermin-leads-significant-mash-improvement-phase-2-trial